Casma Therapeutics
Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.
About
Casma Therapeutics is a biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases. They leverage a deep understanding of cellular and molecular mechanisms to create innovative treatments. The company's approach aims to address the underlying causes of these conditions, offering new hope for patients with unmet medical needs. Teams look it up for Biotechnology, Pharmaceuticals, Drug Discovery.
Frequently asked
What does Casma Therapeutics do?
Casma Therapeutics is a Biotechnology company that offers Platform. Teams look it up for Pharmaceuticals, Drug Discovery, HealthTech. It is based in Cambridge, United States and was founded in 2021. Public records show $46M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Casma Therapeutics raised?
Casma Therapeutics has raised a total of $46M in funding. The most recent round on record is Series C.
Where is Casma Therapeutics headquartered?
Casma Therapeutics is headquartered in Cambridge, United States.
When was Casma Therapeutics founded?
Casma Therapeutics was founded in 2021.
What industry does Casma Therapeutics operate in?
Casma Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech, Autophagy.
What is Casma Therapeutics's current status?
Casma Therapeutics's current operating status is: Inactive.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.